Accessibility Menu
Ventripoint Diagnostics logo

Ventripoint Diagnostics

(OTC) VPTDF

Current Price$0.08
Market Cap$15.54M
Since IPO (2011)-96%
5 Year-75%
1 Year-10%
1 Month-28%

Ventripoint Diagnostics Financials at a Glance

Market Cap

$15.54M

Revenue (TTM)

CA$179.92K

Net Income (TTM)

-CA$3.20M

EPS (TTM)

-$0.01

P/E Ratio

-5.81

Dividend

$0.00

Beta (Volatility)

0.54 (Low)

Price

$0.08

Volume

360,325

Open

$0.08

Previous Close

$0.08

Daily Range

$0.08 - $0.09

52-Week Range

$0.06 - $0.14

Estimated Earnings Date

Jun 15, 2026

VPTDF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ventripoint Diagnostics

Industry

Healthcare Equipment and Supplies

CEO

Hugh MacNaught

Headquarters

Toronto, ON M6P 1T4, CA

VPTDF Financials

Key Financial Metrics (TTM)

Gross Margin

83%

Operating Margin

-19%

Net Income Margin

-18%

Return on Equity

0%

Return on Capital

85%

Return on Assets

-7%

Earnings Yield

-17.21%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.54M

Shares Outstanding

192.58M

Volume

360.32K

Avg. Volume

78.22K

Financials (TTM)

Gross Profit

CA$118.59K

Operating Income

-CA$3.40M

EBITDA

-CA$3.34M

Operating Cash Flow

-CA$1.55M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.55M

Cash & ST Invst.

CA$55.34K

Total Debt

CA$2.60M

Ventripoint Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CA$4.30K

N/A

Gross Profit

-CA$11.12K

N/A

Gross Margin

-2.59%

N/A

Market Cap

$15.54M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

-CA$199.59K

+81.2%

EBITDA

-CA$722.58K

+31.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CA$55.34K

-8.6%

Total Debt

CA$2.60M

+59.0%

Accounts Receivable

CA$132.88K

-47.1%

Inventory

CA$0.00

N/A

Long Term Debt

CA$115.27K

-45.7%

Short Term Debt

CA$2.48M

+74.6%

Return on Assets

-6.78%

N/A

Return on Invested Capital

84.96%

N/A

Free Cash Flow

-CA$598.88K

+16.9%

Operating Cash Flow

-CA$598.88K

+16.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LUFFFHerbal Dispatch Inc.
$0.04+2.79%
ASAPFAurora Spine Corporation
$0.16-7.02%
ALRTFALR Technologies Inc.
$0.02+0.00%
NUMIFNuminus Wellness Inc.
$0.02+2.92%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$14.98+0.02%
INTCIntel
$124.57+0.07%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%

Questions About VPTDF

What is the current price of Ventripoint Diagnostics?

Ventripoint Diagnostics is trading at $0.08 per share.

What is the 52-week range for Ventripoint Diagnostics?

Over the past 52 weeks, Ventripoint Diagnostics has traded between $0.06 and $0.14.

How much debt does Ventripoint Diagnostics have?

As of the most recent reporting period, Ventripoint Diagnostics reported total debt of CA$1.90M.

How much cash does Ventripoint Diagnostics have on hand?

Ventripoint Diagnostics reported CA$40.41K in cash and cash equivalents in its most recent financial results.

What is Ventripoint Diagnostics’s dividend yield?

Ventripoint Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.